Bharat Biotech starts Phase III trials for COVAXIN.Bharat Biotech’s Phase-3 trials will involve 26,000 volunters from 25 centres in India.It’s the largest clinical trial that will be conducted in India .The volunteers will receive two intramuscular injections in a gap of 28 days.
According to Sushitra Ella , Joint Managing Director of Bharat Biotech “The development and clinical evaluation of COVAXIN™ marks a significant milestone for vaccinology in India, for a novel vaccine. It is important for Indian companies to innovate and develop indigenous vaccines, especially during a pandemic. COVAXIN™ has garnered interest from several countries worldwide for supplies and introduction.”
The 25 centers where phase – 3trials will be conducted are as follows
The food we consume plays a crucial role in our overall health and well-being. Unfortunately,…
Lung cancer, the leading cause of cancer-related deaths worldwide, is often associated with smoking as…
Discover the transformative power of a daily 40-minute walk and its incredible health benefits for…
Explore the transformative benefits of no-oil cooking and how eliminating added fats can enhance your…
Discover the remarkable health benefits of drinking papaya leaf water three times a week, from…
Discover the top healthy diets designed to boost heart health, from the Mediterranean to plant-based…